Application of Controlled Release Mechanisms in Vaccine Delivery

Yuhan Xu

doi:10.62051/ijphmr.v2n2.03

Authors

Yuhan Xu

DOI:

https://doi.org/10.62051/ijphmr.v2n2.03

Keywords:

Controlled release, Vaccine delivery, Vaccine design, Intelligent delivery system

Abstract

Vaccines, as an essential means of preventive medicine, profoundly impact human health by stimulating an immune response to protect the body from pathogens or treat diseases. However, conventional vaccine delivery methods have limitations such as multiple injections, rapid degradation in vivo, and difficulty in targeted delivery. The development of controlled release mechanisms has overcome these challenges, optimized the immune response and improved the efficacy and safety of vaccines by precisely controlling the time, space and dose of vaccine release in vivo. This review explores the fundamentals, recent applications and future directions of controlled release mechanisms in vaccine delivery, focusing on the design and application of intelligent delivery systems such as biodegradable nanoparticles, self-healing microspheres, scaffolded vaccines and targeted vaccine systems. With the continuous progress of biotechnology and nanotechnology, controlled-release vaccines herald a new direction in vaccine design and delivery and bring efficient vaccine products to global public health.

References

[1] Kaufmann, S.H., Juliana McElrath, M., Lewis, D.J. and Del Giudice, G. (2014). Challenges and responses in human vaccine development. Current Opinion in Immunology, 28(1), 18-26.

[2] Irvine, D.J., Swartz, M.A. and Szeto, G.L. (2013). Engineering synthetic vaccines using cues from natural immunity. Nature Materials, 12(11), 978-990.

[3] Malek-Khatabi, A., Tabandeh, Z., Nouri, A., Mozayan, E., Sartorius, R., Rahimi, S. and Jamaledin, R. (2022). Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers. ACS Applied Bio Materials, 5(11).

[4] Schwendeman, S.P., Shah, R.B., Bailey, B.A. and Schwendeman, A.S. (2014). Injectable controlled release depots for large molecules. Journal of Controlled Release, 190(1), 240-253.

[5] Tenchov, R., Bird, R., Curtze, A.E. and Zhou, Q. (2021). Lipid Nanoparticles—From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano, 15(11).

[6] Desai, K.-G.H., Kadous, S. and Schwendeman, S.P. (2013). Gamma Irradiation of Active Self-healing PLGA Microspheres for Efficient Aqueous Encapsulation of Vaccine Antigens. Pharmaceutical research, 30(7), 1768-1778.

[7] Marshall, S., Sahm, L.J. and Moore, A.C. (2016). The success of microneedle-mediated vaccine delivery into skin. Human Vaccines & Immunotherapeutics, 12(11), 2975-2983.

[8] Mazzara, J.M., Ochyl, L.J., Hong, J.K.Y., Moon, J.J., Prausnitz, M.R. and Schwendeman, S.P. (2018). Self-healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches. Bioengineering & Translational Medicine, 4(1), 116-128.

[9] Li, X., Xing, R., Xu, C., Liu, S., Qin, Y., Li, K., Yu, H. and Li, P. (2021). Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants. Carbohydrate Polymers, 264(2021), p.118050.

[10] Abasian, P., Ghanavati, S., Rahebi, S., Nouri Khorasani, S. and Khalili, S. (2020). Polymeric nanocarriers in targeted drug delivery systems: A review. Polymers for Advanced Technologies, 31(12), 2939-2954.

[11] Saurabh Bhatia (2016). Natural Polymer Drug Delivery Systems Nanoparticles, Plants, and Algae. Cham Springer International Publishing, 95-118.

[12] Schwendeman, S.P. (2002). Recent Advances in the Stabilization of Proteins Encapsulated in Injectable PLGA Delivery Systems. Critical Reviews in Therapeutic Drug Carrier Systems, 19(1), 73-98.

[13] Desai, K.-G.H. and Schwendeman, S.P. (2013). Active self-healing encapsulation of vaccine antigens in PLGA microspheres. Journal of Controlled Release, 165(1),62-74.

[14] Shah, R.B. and Schwendeman, S.P. (2014). A biomimetic approach to active self-microencapsulation of proteins in PLGA. Journal of Controlled Release, 196(1), 60-70.

[15] Rives, C.B., Anne des Rieux, Zelivyanskaya, M., Stock, S.R., Lowe, W.L. and Shea, L.D. (2009). Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials, 30(3), 394-401.

[16] Zhang, Y., Xu, J., Fei, Z., Dai, H., Fan, Q., Yang, Q., Chen, Y., Wang, B. and Wang, C. (2021). 3D Printing Scaffold Vaccine for Antitumor Immunity. Advanced Materials, 33(48), 2106768.

[17] Najibi, A.J., Dellacherie, M.O., Shih, T., Doherty, E.J., White, D.A., Bauleth-Ramos, T., Stafford, A.G., Weaver, J.C., Yeager, C.D., Seiler, B.T., Pezone, M., Li, A.W., Sarmento, B., Santos, H.A., Mooney, D.J. and Gu, L. (2022). Scaffold Vaccines for Generating Robust and Tunable Antibody Responses. Advanced Functional Materials, 32(16), 2110905.

[18] Chi, Y., Zhang, S. and Ji, S. (2024). Delivery of a Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain Using Bacterial Ghosts. Biomedicines, 12(3), 525-525.

[19] Sheweita, S.A., Batah, A.M., Ghazy, A.A., Hussein, A. and Amara, A.A. (2019). A new strain of Acinetobacter baumannii and characterization of its ghost as a candidate vaccine. Journal of Infection and Public Health, 12(6), 831-842.

[20] Chen, H., Ji, H., Kong, X., Lei, P., Yang, Q., Wu, W., Jin, L. and Sun, D. (2021). Bacterial Ghosts-Based Vaccine and Drug Delivery Systems. Pharmaceutics, 13(11),1892.

[21] Batah, A.M. and Ahmad, T.A. (2020). The development of ghost vaccines trials. Expert Review of Vaccines, 19(6), 549-562.

[22] Shaikh, M.S., Donnan, R. and Dubrovka, R. (2022). Externally Triggered Drug Delivery Techniques Using Micro and Nanoparticles. IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology, 6(3), 380-390.

[23] Mo, S., Coussios, C.-C., Seymour, L. and Carlisle, R. (2012). Ultrasound-enhanced drug delivery for cancer. Expert Opinion on Drug Delivery, 9(12), 1525-1538.

[24] Linsley, C.S. and Wu, B.M. (2017). Recent advances in light-responsive on-demand drug-delivery systems. Therapeutic Delivery, 8(2), 89-107.

[25] Meng, E. and Hoang, T. (2012). Micro- and nano-fabricated implantable drug-delivery systems. Therapeutic Delivery, 3(12), 1457-1467.

[26] Liu, S., Jiang, Q., Zhao, X., Zhao, R., Wang, Y., Wang, Y., Liu, J., Shang, Y., Zhao, S., Wu, T., Zhang, Y., Nie, G. and Ding, B. (2020). A DNA nanodevice-based vaccine for cancer immunotherapy. Nature Materials, 20(3), 421-430.